Increasing Emphasis of Preclinical Imaging in Medical Sector has Boomed PrecliniPosted by Apeksha on July 16th, 2021 Preclinical Imaging Market Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) - Global Forecast Till 2027 Market Insights The global preclinical imaging market is likely to expand significantly at a CAGR of 6.3% by 2023. The market, in the past, gained a valuation of approximately USD 2.01 billion in 2017, which is projected to surge in the upcoming years, according to Market Research Future Reports. The swift increase in the technological advancements in clinical organizations, pharmaceutical companies, and research and development activities in clinical research organization is thrusting the demand for preclinical imaging in the current time. It has also been observed that due to favorable aspects and optimum applications of preclinical imaging, the market of the same is booming year by year and is also expected to bring marvelous opportunities in the forecast period. Regional Outlook The preclinical imaging market segmented regionally into North America, Europe, Asia-Pacific, and the Middle East & Africa. Key Market Players Market Research Future Reports have included some of the best market leaders, who are listed as Bruker Corporation (US), MR Solutions (UK), PerkinElmer (US), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), Miltenyi Biotec GmbH (Germany), LI-COR, Inc. (US), Aspect Imaging (Israel), Trifoil Imaging (US) Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/preclinical-imaging-market-7365 Contact: Akash Anand Market Research Future +1 646 845 9312 Like it? Share it! More by this author |